ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Pennsylvania » Specialist

Top Specialist Prescribers in Pennsylvania

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
RICHARD PISH MD

Specialist

45,691

$2.88M

1042
871 are 65+

6%
patients receiving schedule two controlled substances

Avg: 7%

10%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 28%

$63
Average prescription price

Avg: $89

DAVID HARINSTEIN MD

Specialist

29,394

$1.56M

795
643 are 65+

6%
patients receiving schedule two controlled substances

Avg: 7%

20%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 28%

$53
Average prescription price

Avg: $89

KEN GIBSON MD

Specialist

28,316

$1.49M

1299
1046 are 65+

6%
patients receiving schedule two controlled substances

Avg: 7%

10%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 28%

$53
Average prescription price

Avg: $89

HOUSSAM ABDUL-AL M.D.

Specialist

23,217

$1.18M

489
376 are 65+

17%
patients receiving schedule two controlled substances

Avg: 7%

11%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 28%

$51
Average prescription price

Avg: $89

JOHN JAGEMAN M.D.

Specialist

21,714

$1.26M

573
530 are 65+

8%
patients receiving schedule two controlled substances

Avg: 7%

21%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 28%

$58
Average prescription price

Avg: $89

JALIT TUCHINDA M.D.

Specialist

21,498

$1.28M

787
688 are 65+

3%
patients receiving schedule two controlled substances

Avg: 7%

8%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 28%

$59
Average prescription price

Avg: $89

DONALD SCHOWALTER MD

Specialist

20,954

$1.3M

946
893 are 65+

8%
patients receiving schedule two controlled substances

Avg: 7%

10%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 28%

$62
Average prescription price

Avg: $89

SRIDHAR PATNAM M.D.

Specialist

20,229

$1.12M

549
472 are 65+

7%
patients receiving schedule two controlled substances

Avg: 7%

20%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 28%

$55
Average prescription price

Avg: $89

ANTHONY IANNAMORELLI M.D.

Specialist

19,855

$1.14M

519
412 are 65+

3%
patients receiving schedule two controlled substances

Avg: 7%

9%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 28%

$57
Average prescription price

Avg: $89

ROBERT SCHMIDT M.D.

Specialist

18,059

$1.01M

427
261 are 65+

26%
patients receiving schedule two controlled substances

Avg: 7%

16%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 28%

$56
Average prescription price

Avg: $89

LEWIS WHITMAN MD

Specialist

17,438

$891K

638
578 are 65+

10%
patients receiving schedule two controlled substances

Avg: 7%

11%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 28%

$51
Average prescription price

Avg: $89

MATTHEW D'ONOFRIO MD

Specialist

16,882

$1.15M

861
801 are 65+

4%
patients receiving schedule two controlled substances

Avg: 7%

5%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 28%

$68
Average prescription price

Avg: $89

RICHARD COOK M.D.

Specialist

16,835

$936K

723
594 are 65+

4%
patients receiving schedule two controlled substances

Avg: 7%

6%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 28%

$56
Average prescription price

Avg: $89

ERIC WEAVERLING MD

Specialist

15,929

$807K

682
585 are 65+

2%
patients receiving schedule two controlled substances

Avg: 7%

7%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 28%

$51
Average prescription price

Avg: $89

GORDON GOLD MD

Specialist

15,282

$1.05M

1169
1001 are 65+

4%
patients receiving schedule two controlled substances

Avg: 7%

13%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 28%

$69
Average prescription price

Avg: $89

V KUMAR MD

Specialist

15,179

$877K

678
539 are 65+

5%
patients receiving schedule two controlled substances

Avg: 7%

17%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 28%

$58
Average prescription price

Avg: $89

JORGE LINDENBAUM MD

Specialist

14,267

$870K

563
389 are 65+

6%
patients receiving schedule two controlled substances

Avg: 7%

13%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 28%

$61
Average prescription price

Avg: $89

LEE CICCARELLI M.D.

Specialist

13,943

$866K

337
313 are 65+

13%
patients receiving schedule two controlled substances

Avg: 7%

9%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 28%

$62
Average prescription price

Avg: $89

NADEEM ISLAM MD

Specialist

13,931

$858K

586
490 are 65+

4%
patients receiving schedule two controlled substances

Avg: 7%

15%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 28%

$62
Average prescription price

Avg: $89

DEAN PETRUCCI DO

Specialist

13,321

$895K

505
407 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

9%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 28%

$67
Average prescription price

Avg: $89

ANDREW JOSEPH MD

Specialist

12,616

$778K

667
611 are 65+

5%
patients receiving schedule two controlled substances

Avg: 7%

13%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 28%

$62
Average prescription price

Avg: $89

ABE FRIEDMAN MD

Specialist

12,567

$600K

933
856 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

18%
prescriptions for brand name drugs

Avg: 28%

$48
Average prescription price

Avg: $89

RICHARD EGAN M.D.

Specialist

12,566

$826K

694
624 are 65+

7%
patients receiving schedule two controlled substances

Avg: 7%

13%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 28%

$66
Average prescription price

Avg: $89

CONCEPTO FLORES MD

Specialist

12,160

$675K

641
497 are 65+

5%
patients receiving schedule two controlled substances

Avg: 7%

9%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 28%

$55
Average prescription price

Avg: $89

JOSEPH LABUDA M.D.

Specialist

12,021

$613K

418
354 are 65+

4%
patients receiving schedule two controlled substances

Avg: 7%

9%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 28%

$51
Average prescription price

Avg: $89

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank